- Home
- HUMA vs KRNY Comparison
HUMA vs KRNY Comparison
Compare HUMA & KRNY Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- HUMA
- KRNY
- Stock Information
- Founded
- HUMA 2004
- KRNY 1884
- Country
- HUMA United States
- KRNY United States
- Employees
- HUMA N/A
- KRNY N/A
- Industry
- HUMA Biotechnology: Pharmaceutical Preparations
- KRNY Savings Institutions
- Sector
- HUMA Health Care
- KRNY Finance
- Exchange
- HUMA Nasdaq
- KRNY Nasdaq
- Market Cap
- HUMA 367.6M
- KRNY 399.1M
- IPO Year
- HUMA N/A
- KRNY 2005
- Fundamental
- Price
- HUMA $2.34
- KRNY $6.60
- Analyst Decision
- HUMA Strong Buy
- KRNY Buy
- Analyst Count
- HUMA 7
- KRNY 2
- Target Price
- HUMA $13.00
- KRNY $7.75
- AVG Volume (30 Days)
- HUMA 3.4M
- KRNY 349.8K
- Earning Date
- HUMA 08-12-2025
- KRNY 07-24-2025
- Dividend Yield
- HUMA N/A
- KRNY 6.68%
- EPS Growth
- HUMA N/A
- KRNY N/A
- EPS
- HUMA N/A
- KRNY N/A
- Revenue
- HUMA $517,000.00
- KRNY $148,135,000.00
- Revenue This Year
- HUMA N/A
- KRNY $2.69
- Revenue Next Year
- HUMA $896.45
- KRNY $24.18
- P/E Ratio
- HUMA N/A
- KRNY N/A
- Revenue Growth
- HUMA N/A
- KRNY 3.61
- 52 Week Low
- HUMA $1.15
- KRNY $5.45
- 52 Week High
- HUMA $9.79
- KRNY $8.59
- Technical
- Relative Strength Index (RSI)
- HUMA 50.49
- KRNY 55.67
- Support Level
- HUMA $2.13
- KRNY $6.41
- Resistance Level
- HUMA $2.80
- KRNY $7.00
- Average True Range (ATR)
- HUMA 0.18
- KRNY 0.17
- MACD
- HUMA 0.01
- KRNY 0.02
- Stochastic Oscillator
- HUMA 35.69
- KRNY 62.35
About HUMA Humacyte Inc.
Humacyte Inc is developing a disruptive biotechnology platform to deliver universally implantable bioengineered human tissues and organs designed to improve the lives of patients and transform the practice of medicine. It develops and manufactures acellular tissues to treat a wide range of diseases, injuries, and chronic conditions. Company's pipeline includes Vascular Trauma, PAD, Dailysis, Acellular Tissue Engineered Vessels, Advanced Organ Systems, Advanced Tissue Constructs.
About KRNY Kearny Financial Corp
Kearny Financial Corp is a federally-chartered stock savings bank. The bank is engaged in the business of attracting deposits from the general public in New Jersey and New York, and using these deposits, together with other funds, to originate or purchase loans for its portfolios and invest in securities. The bank's loan portfolio is chiefly comprised of loans collateralized by commercial and residential real estate. The bank's primary source of income is net interest income.